3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
38
Neoplasms
22
Motor Activity
12
Colorectal Neoplasms
9
Lung Neoplasms
8
Stomach Neoplasms
7
Pain, Postoperative
7
Fatigue
7
Anxiety Disorders
6
Pain
5
Carcinoma, Hepatocellular
5
Rectal Neoplasms
4
Polycystic Ovary Syndrome
4
Leukemia, Myeloid, Acute
4
Depression
4
Colonic Neoplasms
4
Thyroid Neoplasms
3
Stomatitis
3
Squamous Cell Carcinoma of Head and Neck
3
Sleep Initiation and Maintenance Disorders
3
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Malnutrition
3
Liver Neoplasms
3
Head and Neck Neoplasms
3
Agnosia
3
Vomiting
2
Uterine Cervical Neoplasms
2
Urinary Incontinence
2
Interventions
enzalutamide
4
abiraterone
2
Radiotherapy
2
Metastasectomy
2
Abiraterone Acetate
2
testosterone enanthate
1
pembrolizumab
1
disitamab vedotin
1
dactolisib
1
VT-464
1
Radium-223
1
Radiosurgery
1
Prednisone
1
NVP-BKM120
1
Ketoconazole
1
Injections
1
Hydrocortisone
1
Flutamide
1
Cyclophosphamide
1
Crizotinib
1
Control Groups
1
Carboplatin
1
Calcitriol
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Castration-resistant Prostate Cancer
×
Control Groups
×
Clear all
NCT05549778
2023-07-11
PEACe
Jiangnan University
Phase 1/2
Completed
12 enrolled